In vivo production of proteins
US-2015376648-A1 · Dec 31, 2015 · US
Method of treating degenerative diseases
US8952129B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-8952129-B2 |
| Application number | US-93425109-A |
| Country | US |
| Kind code | B2 |
| Filing date | Mar 24, 2009 |
| Priority date | Mar 26, 2008 |
| Publication date | Feb 10, 2015 |
| Grant date | Feb 10, 2015 |
How to read this patent
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
- Title
What the patent document calls the invention.
- Abstract
A short plain-language summary of the technical disclosure.
- Assignees and inventors
Who owns or filed the patent and who is credited as inventor.
- Key dates
Filing, priority, publication, and grant dates set the timeline.
- First independent claim
The legal scope of protection — read this for what is actually claimed.
- CPC / IPC classifications
Technology tags used to group this patent with similar filings.
- Citations and related patents
Prior art links and similar publications in this corpus.
Abstract
Official abstract text for this publication.
Agonists of a non-proteolytically activated receptor can be used in methods for treating a disease or disorder in a subject. The methods comprise administering to the subject a therapeutically effective amount of an agonist, wherein the disease or disorder is scleroderma, macular degeneration, diabetic retinopathy, Huntington's disease, Parkinson's disease, closed head trauma, glaucoma, optic neuritis or allograft vasculopathy.
First claim
Opening claim text (preview).
What is claimed is: 1. A method for treating a disease or disorder in a subject, the method comprising administering to the subject a therapeutically effective amount of an agonist of a non-proteolytically activated thrombin receptor, wherein the disease or disorder is selected from the group consisting of: scleroderma, macular degeneration, diabetic retinopathy, closed head trauma, glaucoma, optic neuritis, and allograft vasculopathy. 2. The method of claim 1…
Assignees
Inventors
Classifications
Patent family
Related publications grouped by family.
External sources
Next steps
Free tools are coming soon. Tell us what you want to track and we'll notify you.
Frequently asked questions
Answers are generated from the same data shown on this page.
- What does patent US8952129B2 cover?
- Agonists of a non-proteolytically activated receptor can be used in methods for treating a disease or disorder in a subject. The methods comprise administering to the subject a therapeutically effective amount of an agonist, wherein the disease or disorder is scleroderma, macular degeneration, diabetic retinopathy, Huntington's disease, Parkinson's disease, closed head trauma, glaucoma, optic n…
- Who is the assignee on this patent?
- Carney Darrell H, Steer Randolph C, Univ Texas
- What technology area does this patent fall under?
- Primary CPC classification A61K38/4833. Mapped technology areas include Human Necessities.
- When was this patent published?
- Publication date Tue Feb 10 2015 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
- What related patents are in patentsdb?
- We list 8 related publications on this page (citations in our corpus or others sharing the same primary CPC).